<?xml version="1.0" encoding="UTF-8"?>
<codeBook>
      <docDscr>
         <citation>
            <titlStmt>
               <titl>Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)</titl>
               <altTitl>Prader-Willi Syndrome Macronutrient Study</altTitl>
            </titlStmt>
         </citation>
      </docDscr>
      <stdyDscr>
         <citation>
            <titlStmt>
               <titl>Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)</titl>
               <altTitl>Prader-Willi Syndrome Macronutrient Study</altTitl>
               <IDNo agency="ClinicalTrials.gov">NCT02011360</IDNo>
            </titlStmt>
            <rspStmt>
               <AuthEnty affiliation="University of Alberta">Haqq, Andrea</AuthEnty>
               <AuthEnty affiliation="Duke University">Freemark, Michael</AuthEnty>
               <AuthEnty affiliation="Duke University">Irizarry, Krystal</AuthEnty>
               <AuthEnty affiliation="Duke University">McCarthy, Mimi</AuthEnty>
               <AuthEnty affiliation="University of Alberta">Mackenzie, Michelle</AuthEnty>
               <AuthEnty affiliation="Duke University">Timberlake, Sarah</AuthEnty>
               <AuthEnty affiliation="University of Alberta">Mager, Diana</AuthEnty>
               <AuthEnty affiliation="Duke University">Newgard, Christopher</AuthEnty>
            </rspStmt>
            <prodStmt>
               <producer affiliation="University of Alberta">Haqq, Andrea<ExtLink URI="http://www.researchgate.net/profile/Andrea_Haqq"/>
               </producer>
               <producer affiliation="Duke University">Freemark, Michael<ExtLink URI="http://www.researchgate.net/profile/Michael_Freemark"/>
               </producer>
               <producer affiliation="Duke University">Irizarry, Krystal<ExtLink URI="http://www.researchgate.net/profile/Krystal_Irizarry"/>
               </producer>
               <prodDate>2014</prodDate>
               <prodPlac>Edmonton, Alberta; Durham, North Carolina</prodPlac>
               <grantNo agency="Foundation for Prader-Willi Research"/>
               <software>Microsoft Excel</software>
               <software>SPSS</software>
               <software>Food Processor Nutrition Analysis Software</software>
               <software>REDCap</software>
            </prodStmt>
            <distStmt>
               <contact affiliation="University of Alberta"
                     email="andrea.haqq@albertahealthservices.ca">Haqq, Andrea</contact>
            </distStmt>
            <serStmt/>
         </citation>
         <dataAccs>
            <useStmt>
               <conditions>Access is limited to selected members of the research team</conditions>
               <restrctn>No direct access for researchers external to the research team</restrctn>
               <restrctn>Given the small population size and risk of reidentification, no direct access will be provided to the data.</restrctn>
               <conditions>Access to the data is limited to selected members of the research team.</conditions>
            </useStmt>
         </dataAccs>
         <stdyInfo>
            <abstract>The purpose of this study is to look at how different types of diets (low carbohydrate or low fat) affect the level of hormones in blood, metabolism, and appetite in children with PWS. The results from this study will provide information that can be used to design evidence-based diet plans for children with PWS.</abstract>
            <subject>
               <keyword vocab="MeSH">ghrelin</keyword>
               <keyword vocab="MeSH">appetite regulation</keyword>
               <keyword vocab="MeSH">pediatrics</keyword>
               <keyword>nutrition</keyword>
               <keyword vocab="MeSH">nutrition disorders</keyword>
               <keyword vocab="MeSH">chromosome disorders</keyword>
               <keyword vocab="MeSH">body weight</keyword>
               <keyword vocab="MeSH">cross-over studies</keyword>
               <keyword vocab="MeSH">prader-willi syndrome</keyword>
               <keyword vocab="MeSH">pediatric obesity</keyword>
            </subject>
            <sumDscr>
               <nation>Canada</nation>
               <geogCover>Alberta, Edmonton, Li Ka Shing Centre for Health Research Innovation</geogCover>
               <nation>United States</nation>
               <geogCover>North Carolina, Durham, Duke University Medical Center</geogCover>
               <timePrd event="start">5/1/2014</timePrd>
               <timePrd event="end">9/1/2017</timePrd>
               <collDate event="start">5/1/2014</collDate>
               <collDate event="end">12/1/2017</collDate>
               <anlyUnit>Individuals</anlyUnit>
               <universe>Children aged 5 years to 17 years with a diagnosis of Prader Willi syndrome confirmed by chromosome analysis.</universe>
               <dataKind>Anthropometric data</dataKind>
               <dataKind>Biosamples</dataKind>
               <dataKind>Clinical data</dataKind>
               <dataKind>Interview data</dataKind>
               <dataKind>Questionnaire data</dataKind>
            </sumDscr>
         </stdyInfo>
         <method>
            <dataColl>
               <sampProc>13 study participants will be recruited through convenience sample.</sampProc>
               <frequenc>Data is collected daily over the four days of the clinical visit.</frequenc>
               <collMode>Face-to-face interview</collMode>
               <collMode>Self-administered questionnaire: Paper</collMode>
               <collMode>Self-administered writings and/or diaries</collMode>
               <collMode>Physical measurements and tests</collMode>
               <collSitu>Suppression of ghrelin will be measured at 10 hour fast following completion of dietary intervention. Fasting labs will be obtained immediately following dietary intervention. These labs will include total and active ghrelin. Changes in subjective hunger will be assessed by an appetite and hyperphagia questionnaire validated for PWS children. Analysis of improvements in insulin sensitivity and inflammatory cytokine profile will include measurements of adiponectin, GLP-1, glucose, insulin, AST, ALT, insulin sensitivity and a detailed profile ('metabolomics') of amino acids, fatty acids, acylcarnitines, and adipocytokines on the day prior to and immediately following dietary intervention. Changes in satiety, improvements in insulin sensitivity, and improvement in inflammatory cytokine profile are measured during the 72 hour dietary intervention.</collSitu>
               <ConOps>Two people check data entry.</ConOps>
            </dataColl>
         </method>
         <othrStdyMat/>
      </stdyDscr>
   </codeBook>
